Osteopontin in Urinary Stone Formation

Annals of the New York Academy of Sciences

Volumn 760, Issue 1, 1995, Pages 257-265

  HOYER, JOHN R ^a   OTVOS, LASZLO ^b   URGE, LASZLO ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM OXALATE; OSTEOPONTIN; UNCLASSIFIED DRUG; UROPONTIN;

CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; MINERALIZATION; NONHUMAN; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEIN STRUCTURE; PROTEIN URINE LEVEL; STONE FORMATION; UROLITHIASIS;

EID: 0029125269     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1995.tb44636.x     Document Type: Article

References (50)

1. The pathogenesis and treatment of kidney stones
2. Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid‐rich protein superfamily
3. Uropontin (UP) inhibits calcium oxalate monohydrate (COM) crystal growth and nucleation
4. Affinity purification of urinary crystal growth inhibitor (CGI)
5. Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone
6. The cDNA and derived amino acid sequence for human osteopontin
7. cDNA cloning, mRNA distribution and heterogeneity, chromosomal location, and RFLP analysis of human osteopontin (OPN)
8. Interactions between acidic proteins and crystals; stereochemical requirements in biomineralizaiton
9. Interactions of sea‐urchin skeleton macromolecules with growing calcite crystals; a study of intracrystalline proteins
10. Mollusk shell organic matrix: Fourier transform infrared study of the acidic macromolecules
11. Secondary structure predicitons for rat osteopontin
12. Calculation of protein conformation from circular dichroism
13. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin
14. ++] in rat osteoclasts and mouse osteoclast‐like cells
15. 3 integrin stimulates immediate cell signals in osteoclasts
16. Osteopontin‐hydroxyapatite interactions in vitro; inhibition of hydroxyapatite formation and growth in a gelatin‐gel
17. Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin‐mediated inhibition of hydroxyapatite formation
18. Tissue specificity and developmental expression of rat osteopontin
19. 3 stimulates synthesis and secretion of nonphosphorylated osteopontin (secreted phosphoprotein 1) in mouse JB6 epidermal cells
20. Transcriptional regulation of osteopontin production in rat osteoblast‐like cells by parathyroid hormone
21. The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone
22. Estrogen inhibition of periostial bone formation in rat long bones; down regulation of gene expression for bone matrix proteins
23. Regulated temporal and spatial expression of the calcium‐binding proteins calycin and OPN (osteopontin) in mouse tissues during pregnancy
24. The mouse osteopontin gene; expression in monocytic lineages and complete nucleotide sequence
25. Cloning and characterization of the human osteopontin gene and its promoter
26. Uropontin is a major matrix component of urinary calcium oxalate monohydrate stones
27. Selective incorporation of uropontin into urinary calcium oxalate monohydrate stones
28. Isolation of acid‐resistant urinary trypsin inhibitors by high performance liquid chromatography and their characterization by N‐terminal amino‐acid sequence determination. Hoppe‐Seyler's Z. Physiol
29. The presence of protein‐bound γ‐carboxy‐glutamic acid in calcium‐containing renal calculi
30. Kidney stone matrix, differences in acid protein composition
31. Distribution of organic matrix in calcium oxalate renal calculi
32. Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin
33. Characterization of urinary uropontin excretion in humans
34. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli
35. Expression and distribution of osteopontin in human tissues; widespread association with luminal epithelial surfaces
36. Distribution of osteopontin in rat kidney; upregulation in ischemia
37. Osteopontin, a transformationassociated cell adhesion phosphoprotein, is induced by 12‐O‐tetradecanoylphorbol 13‐acetate in mouse epidermis
38. Structural and functional studies of the early T lymphocyte activation 1 (Eta‐1) gene; definition of a novel T cell‐dependent response associated with genetic resistance to bacterial infection
39. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques
40. Structure and expression of the mRNA encoding urinary stone protein (osteopontin)
41. Osteopontin expression in the kidney during ureteral obstruction
42. Osteopontin: a protein with diverse functions
43. Molecular abnormality of Tamm‐Horsfall glycoprotein in calcium oxalate nephrolithiasis
44. Normal rat kidney cells secrete both phosphorylated and non‐phosphorylated forms of osteopontin showing different physiologic properties
45. Evidence for the formation of a complex between osteopontin and osteocalcin
46. Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: inductive effects of dexamethasone on the osteoblastic phenotype
47. The dual role of polyelectrolytes and proteins as mineralization promoters and inhibitors of calcium oxalate monohydrate
48. Cell polarity and calcium oxalate crystal adherence to cultured collecting duct cells
49. Experimental calcium oxalate nephrolithiasis in the rat. Role of the renal papillae